produce supplementary measures which will provide a more complete control of the severe stage of diarrheal disease" (4) .
Darrow, at Yale, provided the solution. The studies of experimental potassium deficiency in his laboratory indicated that intracellular potassium loss was attended with serious physiologic consequences, and that the rate of cell uptake of potassium in states of potassium deficiency was sufficiently rapid so that potassium could be given parenterally, contrary to the advice of Butler, McKhann, and Gamble.
Darrow and Helen Hamson and I had given potassium orally to patients with chronic diarrhea and potassium depletion, with salutary effects. Darrow was now convinced that potassium should be included along with sodium chloride and glucose in the parenteral management of acute diarrhea of infancy.
The opportunity to put this theory to the test came in the summer of 1945. There was a severe outbreak of infant diarrhea in Baltimore that summer, and Edwards A. Park asked Darrow to come to the Hamet Lane Home to try to improve the treatment of these infants. In August of 1945, Darrow set up a laboratory to do water and electrolyte balances, and all infants with diarrhea admitted to the Hamet Lane Home were given solutions containing potassium, along with the traditional sodium chloride and glucose.
The balance studies indicated that potassium was retained in amounts compatible with repletion of intracellular potassium (5). The treatment was well tolerated and the mortality rate, as shown in Figure 1 , was reduced after introduction of potassium therapy. This was the first parenteral use of potassium in the world, and potassium is now regarded as an essential component of all parenteral fluid management. It is particularly valuable for patients on prolonged parenteral maintenance and in such conditions as diabetic ketoacidosis and intestinal obstruction. Sufficient recognition has not been given to Darrow, a member of this Society, a former President, and a Howland Awardee, for this extraordinarily important contribution to the health of, not only children, but adults.
The incidence of infant diarrhea in Baltimore continued to be high. At the Baltimore City Hospital (BCH), I decided to see whether an oral electrolyte solution containing sodium and potassium salts along with a low concentration of glucose might make possible rehydration of infants with diarrhea without parenteral therapy. This would facilitate outpatient treatment of many such infants.
The composition of this original BCH solution is given in Table 3 . The concentrations of sodium and potassium in this solution were based on Darrow's balance studies; the concentration of glucose was based on a theoretical calculation as to the amount of glucose that might reduce the negative protein balance to a minimum. The results with this solution were very satisfactory, fulfilling our hopes of outpatient treatment of many cases of infant diarrhea and reducing the requirement for i.v. therapy (6) .
Darrow also studied oral hydration with a solution of somewhat different composition. Within several years, commercial solutions became available, as indicated in Table 3 , but these TREATMENT OF DIARR HEAL DEHYDRATION S63 commercial solutions contained considerably higher concentrations of carbohydrate than the BCH solution. These high concentrations of organic substances probably were responsible for the osmotic diarrhea and hypernatremic dehydration in some infants given these solutions. This set back the use of oral hydration in this country for many years, because the subsequent solutions that were provided were too low in sodium to be of value in the oral hydration of severe diarrhea. Meanwhile, another development had occurred outside the United States. An American naval group had been assigned to study the cholera problem during World War 11, and this investigation was continued after the war ended. Physiologists in this country investigating sodium absorption by the small intestinal mucosa found a linkage between sodium and glucose transport. The possibility was entertained that a solution of sodium and potassium salts containing only that amount of glucose that would facilitate sodium transport, given orally, could prevent patients with cholera from dying of dehydration and hypovolemia. The solution chosen provided 90 mEq of sodium and 20 mEq of potassium/L, exactly the same concentration of potassium as in our original BCH solution. The glucose concentration was somewhat lower, about 2%. The high sodium concentration in this particular solution was selected because stool water concentrations of sodium in cholera are considerably higher than those in infant diarrhea or other etiologies (Table 2) .
This oral hydration solution, after some difficulties, was found to be effective by a number of groups working with cholera in various countries in Asia. The success of an oral electrolyte solution in replacing water and electrolyte losses due to cholera prompted the World Health Organization to promote the use of this solution in infant diarrhea. The 1988 report of the United Nations Children's Fund summarizes the value of this program: "The greatest killer of children, with three million victims a year, is still the dehydration caused by diarrheal disease. Yet dehydration can now be prevented by the technique of oral rehydration therapy." This therapy was estimated to be saving more than 600 000 lives each year. Dr. Henderson's estimate is even higher than that. Granted, oral rehydration is symptomatic therapy. The need for the prevention of diarrhea is still an important problem that requires technologic advances as well as medical contributions. Symptomatic therapy should still be given credit as effective therapy and, in this case, it has been highly valuable in saving lives.
There has been a reciprocal benefit to us from these studies of oral hydration of diarrhea in Third World countries (7) . In this country, suitable commercially marketed solutions for oral replacement of water and electrolyte losses in infant diarrhea are now available, as shown in Table 3 , which gives an example of solutions marketed by one pharmaceutical company; the socalled rehydration solution (R) providing a higher concentration of sodium (75 mEq/L) and the maintenance solution (M) providing a concentration of sodium of 45 mEq/L. Both solutions contain 20 mEq/L of potassium. If we average these two solutions, we arrive at a solution containing 60 mEq/L of sodium, 20 mEq/L of potassium, and 25 g glucose/L. As you can see, this is very close to the composition of the original BCH solution developed more than 40 years ago.
The contribution of American pediatricians to our knowledge of the water and electrolyte deficits resulting from infant diarrhea has thus helped in the development of relatively simple but effective methods of prevention of dehydration due to diarrhea, which still is a major scourge throughout the world. We can take pride as American pediatricians in this benefit to the health of the world's children.
